Market Overview

Sydney Police Intercepts $75m Worth of Drugs in Frozen Fish


Sydney police arrested in Fairfield two men who attempted to bring into the country over 100 kilograms of heroin and methamphetamines worth $75 million by disguising them as liquid in ice packs hidden under frozen fish fillets from Malaysia.


The Herald Sun identified the arrested drug smugglers as a 55- and 57-year-old Vietnamese/Canadian national who arrived in Australia in early September. Police said they brought in 88 kilograms of heroin and 22 kilograms of meth.


Police estimated the drugs they seized from the Fairfield house of the two men would be equal to 780,000 street deals of heroin and 200,000 of ice. The confiscation was the result of a joint operation that involved the federal police, Customs, New South Wales police, the Australian Crime Commission, and NSW Crime Commission.


The two appeared on Friday before the Sydney Central Local Court.


Besides the smuggled drugs, there is a surge in prescription opioid abuse in Australia from doctors. Some of the more known brands are Oxycontin, Endone and Targin. However, observers have noticed the shift from lawfully manufactured substances to heroin. The Australian Crime Commission is already preparing measures to counter the expected boost of heroin trade in Australia.


“There’s a large increase in heroin use now in USA, and both the administrator of the DEA and the FBI director, both were advising me, ‘Look, watch out. There’s a trend there that we’ve seen happen in the States which we would expect would come in Australia,’” said Chris Dawson, the new CEO of the Australian Crime Commission.


Fortunately, both in the U.S. and Australia, there are treatment programs available that offer high rates of success in addressing alcohol and opioid addiction problems. In the United States, one such program comes from BioCorRx, Inc. (OTCQB: BICX), which has developed an innovative approach to alcohol and opioid abuse treatment called the Start Fresh Program that is believed by some experts to be a “game-changer” in the rehabilitation sector. The Start Fresh Program is a two-tiered program used by local addiction clinics across the United States which involves an outpatient medical procedure and psycho-social coaching. Some Australian clinics also offer similar programs.


BioCoRx’s first component involves an outpatient medical procedure to embed a biodegradable naltrexone implant under the abdominal skin and fatty tissue. The implant then delivers therapeutic levels of the antagonist drug, naltrexone, into the bloodstream which can curb one’s cravings for alcohol or opioids.


The second tier of the program involves a private, one-on-one coaching program to address the specific needs of the alcoholics and addicts, as well as to help him or her plan for a life free from substance abuse.


“Our program originated in Australia, but has evolved over the years. Australia has been at the forefront of addiction treatment using Naltrexone implants and we thank them for that,” said Brady Granier, COO of BioCorRx.


Learn more information about the Start Fresh Program and about possible investment opportunities with BioCorRx, Inc. by visiting its new investor relations website

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.


Related Articles (BICX)

View Comments and Join the Discussion!

U.S. Bank, Appraiser and Officer Fined Over Discrimination Against American Couple

Distributed Control Systems Global Market Worth USD 20.39 Billion by 2020 Research Report - GrandViewResearch